Condition
Diffuse Midline Glioma clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Diffuse Midline Glioma clinical trials that are recruiting, at sites in 2 countries (most in United States (3), Italy (2)). 1 was first registered in the last 30 days. By phase: Phase 1 (2), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 1New in 30 days
- 2Countries
Newest Diffuse Midline Glioma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Pulsed Low-Dose-Rate Radiotherapy for Diffuse Midline Glioma | — | Aviano, Pordenone | Recruiting | Nov 5, 2026 |
| BCB-276 CAR T therapy for DIPG in children and young adults | Phase 2 | Los Angeles, California and 5 other locations | Recruiting | Jul 2, 2026 |
| CAR T-cell therapy for pediatric brain tumors | Phase 1 | Roma, Italy | Recruiting | Mar 28, 2022 |
| Locoregional immunotherapy using CAR T cells for pediatric brain tumors | Phase 1 | Seattle, Washington | Recruiting | Dec 4, 2019 |
| Registry for patients with Diffuse Intrinsic Pontine Glioma and Diffuse Midline Glioma | — | Cincinnati, Ohio | Recruiting | Apr 5, 2017 |
All recruiting trials (5)
-
Pulsed Low-Dose-Rate Radiotherapy for Diffuse Midline Glioma
This study tests whether pulsed low-dose-rate radiotherapy can be tolerated by patients with diffuse midline glioma, especially children, and helps identify a safe dose for future use.
-
BCB-276 CAR T therapy for DIPG in children and young adults
This study tests BCB-276, a patient's own CAR T cells against DIPG, after standard radiation, to see if it is safe and can help extend survival.
-
CAR T-cell therapy for pediatric brain tumors
This study is testing a new CAR T-cell therapy for kids and young adults with tough brain tumors to see if it can safely help them when other treatments have failed.
-
Locoregional immunotherapy using CAR T cells for pediatric brain tumors
This study is testing a new treatment using specially modified immune cells to see if it can help children and young adults with certain types of brain tumors feel better.
-
Registry for patients with Diffuse Intrinsic Pontine Glioma and Diffuse Midline Glioma
This study is creating a registry to collect information and tissue samples from patients with Diffuse Intrinsic Pontine Glioma and Diffuse Midline Glioma to help improve how these tumors are diagnosed and treated.
Related topics
Quick answers
How many Diffuse Midline Glioma clinical trials are recruiting right now?
5, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (3 trials), Italy (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.